Log In
Print this Print this


Also known as: AZD-3965

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionMonocarboxylate transporter 1 (MCT1) inhibitor
Molecular Target Monocarboxylate transporter 1 (MCT1)
Mechanism of ActionMonocarboxylate transporter 1 (MCT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerCancer Research Technology Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today